港股異動 | 周生生跌近6% 3月上旬各地銷售額大跌
格隆匯3月23日丨周生生(00116.HK)跌近6%,報10.16港元,總市值69億港元。周生生公吿,截至2021年12月31日止12個月,公司收益為219.88億港元,同比增長47%;公司擁有人應占溢利為6.43億港元,同比增長18%;每股盈利為95港仙,每股末期股息28港仙。該公司表示,與去年同期相比,香港和澳門1月和2月的銷售下降14%,而3月上旬下降約60%。內地1月和2月的銷售按年增長12%,但3月上旬的銷售卻下降約30%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.